Henry Schein, Inc. revised earnings guidance for the year 2014. The company expects the Arseus transaction to be dilutive to earnings per share in 2014 by approximately $0.03. The company now expects diluted EPS attributable to the company to be $5.29 to $5.39, which represents growth of 8% to 10% compared with the midpoint of the 2013 guidance range.

Guidance for 2014 diluted EPS attributable to the company is for current continuing operations as well as completed or previously announced acquisitions, and does not include the impact of other potential future acquisitions, if any.